Claritev Corporation

NYSE:CTEV

Medical - Healthcare Information Services

Healthcare
$22.30 +1.41%

+$0.42 today

Market cap
$380.77M
Beta
0.77
P/E (TTM)
-1.8
EPS (TTM)
-$17.16
52W Low $11.50High $74.07

Volume 0.31M

Average 0.14M

CTEV Acquisitions (Net)

Cash paid for acquiring businesses, net of cash acquired.

Claritev CorporationNYSE: CTEV

Acquisitions (Net) · Q1 FY2026 · quarter ended Mar 2026

Acquisitions (net) outflow grows to $0

Q1 FY2026 acquisitions (net) was $0, compared with $0 a year earlier. Trailing-twelve-month acquisitions (net) was $0.

Context

  • Acquisitions (net) amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Acquisitions (net) increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly acquisitions (net) holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Acquisitions (Net) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Acquisitions (Net) history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Acquisitions (Net) vs competitors

How CTEV compares with its peers on the latest reported figures

  • CTEV's LTM Mar 2026 acquisitions (net) of $0 is the 4th largest of the 11 companies compared; the peer median is $0.
  • Acquisitions (net) amounts to 0.0% of revenue for CTEV, versus a peer median of 0.0%.
CTEV Competitors Peer median
Acquisitions (Net) for CTEV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OPKOPKO Health, Inc.LTM Mar 2026$197.77M +2540.7%—34.0%
EVHEvolent Health, Inc.LTM Mar 2026$52.95M +80.5%—2.8%
SANASana Biotechnology, Inc.LTM Mar 2026$1.02M +302.8%——
CTEVClaritev CorporationLTM Mar 2026$0 ——0.0%
DNTHDianthus Therapeutics, Inc.LTM Jun 2026$0 ——0.0%
AXGNAxoGen, Inc.LTM Sep 2026$0 ——0.0%
GDRXGoodRx Holdings, Inc.LTM Mar 2026$0 +100.0%-42.2%0.0%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$0 +100.0%—0.0%
IRMDIRadimed CorporationLTM Mar 2026$0 ——0.0%
INMDInMode Ltd.LTM Mar 2026$0 ——0.0%
LFMDLifeMD, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding CTEV) $0+100.0%-42.2%0.0%

Competitors are the stored peer set for CTEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income102.08M(572.91M)(91.7M)(1.65B)(284.28M)
Depreciation & Amortization424.32M415.66M425.79M436.44M445.43M
Deferred Income Tax(81.93M)(114.38M)(114.06M)(198.01M)(128.51M)
Stock-Based Compensation18.01M16.74M18.02M26.65M27.82M
Change in Working Capital(46.68M)55.34M(21.91M)(13.67M)(28.87M)
Accounts Receivables(33.83M)21M4.4M(13.2M)(26.57M)
Inventory00000
Accounts Payables7.71M34.35M5.58M42.22M(25.86M)
Other Working Capital(12.85M)34.34M(26.31M)(42.69M)23.57M
Other Non-Cash Items(93.04M)571.92M(44.42M)1.5B85.73M
Operating Cash Flow404.69M372.36M171.72M107.62M117.32M
Capital Expenditures(84.59M)(89.74M)(108.85M)(118.12M)(129.6M)
Acquisitions (Net)(149.43M)0(140.94M)00
Purchases of Investments0(15M)000
Sales of Investments0289K0016M
Other Investing Activities5.64M000(7.42M)
Investing Cash Flow(228.38M)(104.45M)(249.79M)(118.12M)(121.02M)
Debt Repayment(10.9M)(13.28M)(165.82M)(28.07M)4.72M
Common Stock Issued00508K01.74M
Common Stock Repurchased(103.79M)(100M)(15.22M)(10.37M)0
Dividends Paid00000
Other Financing Activities(3.79M)(2.46M)(465K)(2.88M)(4.1M)
Financing Cash Flow(114.68M)(115.74M)(180.99M)(41.32M)2.36M
Effect of Forex Changes00000
Net Change in Cash61.62M152.18M(259.07M)(51.82M)(1.33M)
Free Cash Flow320.1M282.63M62.87M(10.51M)(12.28M)

Claritev Corporation

NYSE:CTEV

Intrinsic Alpha fair value

Locked

Current Price

$22.30

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.